Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Study of Preoperative Chemoradiotherapy With Gemcitabine for Resectable Pancreatic Carcinoma

NCT01333124 is registered in ClinicalTrials.gov with National Cancer Center, Korea as lead sponsor.

NCT NCT01333124
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01333124 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Study of Preoperative Chemoradiotherapy With Gemcitabine for Resectable Pancreatic Carcinoma
Lead sponsor
National Cancer Center, Korea
Phase
Phase 2
Overall status
Terminated
Start date
September 28, 2011
Completion date
December 31, 2017
Enrollment
23 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

resectable pancreatic carcinoma